Join Biomodels' Scientists, Andrew Borkowski and Nicole Smith, to learn about translational and predictive animal models of Inflammatory Bowel Disease (IBD), Graft versus Host Disease (GVHD), and pulmonary disease! When: April 4, 2024 at 11am ET Register here: https://bit.ly/3P7m0sg
BioModels’ Post
More Relevant Posts
-
I am attend the CME about Novel Approaches to Alpha-1 Antitrypsin deficiency-related liver disease:A congress update on June 25,2024 In this activity I learned new Approaches&characteristics regard this disease through #medscape
-
-
Join us at #EASLCongress 2024 for a session on bridging the gap between metabolic and alcohol-related liver disease! Explore crucial questions on defining MetALD, non-invasive liver fibrosis tests, management strategies, and more. https://bit.ly/3UhxA5W
-
-
Tonight at 18:00 CEST: Challenging cases in interstitial lung disease: solving mysteries This case-based webinar will see the experts discuss the most challenging case studies in the field of interstitial lung disease (ILD), and how to manage them. Find out more and register now: https://lnkd.in/ed5iq2zU
-
-
This study provides the first single-nucleus transcriptomic atlas of human pericoronary epicardial adipose tissue in coronary artery disease. https://lnkd.in/gJ7xnKCt
-
-
It's so interesting to see how different rare disease research is in comparison to other clinical trials. Discover the nuances of rare disease studies and how our team at Worldwide utilizes an innovative and personalized approach to ensure your trial has the best chance of success: https://bit.ly/4gPITfX
-
-
It's so interesting to see how different rare disease research is in comparison to other clinical trials. Discover the nuances of rare disease studies and how our team at Worldwide utilizes an innovative and personalized approach to ensure your trial has the best chance of success: https://bit.ly/3XWErDB
-
-
Medical Director | Medical Affairs | Physician Consultant | Cell & Gene Therapy Advisor | Drug Safety Physician — Hematology, Oncology & Rare Diseases
It's so interesting to see how different rare disease research is in comparison to other clinical trials. Discover the nuances of rare disease studies and how our team at Worldwide utilizes an innovative and personalized approach to ensure your trial has the best chance of success: https://bit.ly/3XYgFXB
-
-
Doctor, Associate Editor at the British Association of Dermatologists (Skin Health and Disease), Research Scientist (Immuno-Dermatology) at University of Oxford. Dermatology mad!
New paper out today! Read all about how spatial transcriptomic profiling can aid our understanding of skin disease! https://lnkd.in/eMid2tvZ #skindisease #skinresearch #spatialtranscriptomics #skincancer #ST #genes #transcriptomicprofiling #skintissue #skinawareness
-
-
Pharmaceutical Industry, Senior Clinical Trial Manager, Worldwide Clinical Trials | Clinical Operations, Clinical Project Management and Line Management experience.
It's so interesting to see how different rare disease research is in comparison to other clinical trials. Discover the nuances of rare disease studies and how our team at Worldwide utilizes an innovative and personalized approach to ensure your trial has the best chance of success: https://bit.ly/3XVWFVR
-
-
Driving exponential business growth through innovative solutions and dynamic client relationships
It's so interesting to see how different rare disease research is in comparison to other clinical trials. Discover the nuances of rare disease studies and how our team at Worldwide utilizes an innovative and personalized approach to ensure your trial has the best chance of success: https://bit.ly/3Yakr1z
-
Thank you Scientist.com for hosting our webinar! We're looking forward to it!